Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
05
2021
accepted:
29
07
2021
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
24
9
2021
Statut:
epublish
Résumé
Prenatal care providers will play an important role in the acceptance of SARS-Cov-2 vaccination for pregnant women. To determine the perceptions of French prenatal care providers: midwives, general practitioners (GPs) and obstetricians and gynaecologists (Ob-Gyn) regarding SARS-CoV-2 vaccination during pregnancy. An anonymous online survey was sent to members of French professional societies representing prenatal practitioners. The participants were asked to answer questions on their characteristics and give their opinions of the SARS-CoV-2 vaccine for themselves and women who are pregnant or willing to become pregnant. Access to the survey was opened from January 11th, 2021, to March 1st, 2021. A total of 1,416 responses were collected from 749 Ob-Gyn, 598 midwives and 69 GPs. Most respondents (86.7% overall, 90.4% for Ob-GYN, 81.1% for GPs and 80.1% for midwives) agreed to receive the SARS-CoV-2 vaccine. Vaccination against SARS-CoV-2 would be offered to pregnant women by 49.4% 95%CI [48.1-50.8] of the participants. Midwives were less likely to recommend vaccination than GP and Ob-Gyn (37.5%, 50.7% and 58.8%, respectively). The multinomial logistic regression revealed that being an obstetrician, working in a group, usually offering a flu vaccine and wanting to be vaccinated against SARS-CoV-2 were positively associated with considering pregnant women for SARS-CoV-2 vaccination. Most French prenatal healthcare providers are favourable towards vaccinating pregnant women, but a large minority express reservation. More evidence on safety and involvement by professional organisations will be important to encourage the access of pregnant women to vaccination against SARS-CoV-2.
Sections du résumé
BACKGROUND
Prenatal care providers will play an important role in the acceptance of SARS-Cov-2 vaccination for pregnant women.
OBJECTIVE
To determine the perceptions of French prenatal care providers: midwives, general practitioners (GPs) and obstetricians and gynaecologists (Ob-Gyn) regarding SARS-CoV-2 vaccination during pregnancy.
STUDY DESIGN
An anonymous online survey was sent to members of French professional societies representing prenatal practitioners. The participants were asked to answer questions on their characteristics and give their opinions of the SARS-CoV-2 vaccine for themselves and women who are pregnant or willing to become pregnant.
RESULTS
Access to the survey was opened from January 11th, 2021, to March 1st, 2021. A total of 1,416 responses were collected from 749 Ob-Gyn, 598 midwives and 69 GPs. Most respondents (86.7% overall, 90.4% for Ob-GYN, 81.1% for GPs and 80.1% for midwives) agreed to receive the SARS-CoV-2 vaccine. Vaccination against SARS-CoV-2 would be offered to pregnant women by 49.4% 95%CI [48.1-50.8] of the participants. Midwives were less likely to recommend vaccination than GP and Ob-Gyn (37.5%, 50.7% and 58.8%, respectively). The multinomial logistic regression revealed that being an obstetrician, working in a group, usually offering a flu vaccine and wanting to be vaccinated against SARS-CoV-2 were positively associated with considering pregnant women for SARS-CoV-2 vaccination.
CONCLUSION
Most French prenatal healthcare providers are favourable towards vaccinating pregnant women, but a large minority express reservation. More evidence on safety and involvement by professional organisations will be important to encourage the access of pregnant women to vaccination against SARS-CoV-2.
Identifiants
pubmed: 34516551
doi: 10.1371/journal.pone.0256080
pii: PONE-D-21-15049
pmc: PMC8437278
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0256080Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pediatr Infect Dis J. 2019 Sep;38(9):944-951
pubmed: 31261362
Am J Obstet Gynecol MFM. 2021 Jul;3(4):100352
pubmed: 33771762
Vaccine. 2018 Oct 22;36(44):6531-6539
pubmed: 29483029
Vaccine. 2021 Jan 8;39(2):171-172
pubmed: 33308888
JAMA. 2021 Mar 16;325(11):1039-1040
pubmed: 33555297
Vaccine. 2020 Jan 29;38(5):1144-1151
pubmed: 31810781
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
Nature. 2020 Dec;588(7837):205-206
pubmed: 33288887
Obstet Gynecol. 2000 Jul;96(1):81-4
pubmed: 10862847
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231
pubmed: 33320401
Obstet Gynecol. 2020 Aug;136(2):303-312
pubmed: 32516273
PLoS One. 2019 Oct 31;14(10):e0224330
pubmed: 31671115
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Am J Prev Med. 2003 Aug;25(2):144-50
pubmed: 12880883
Vaccine. 2016 Sep 22;34(41):5013-5020
pubmed: 27576074
JAMA. 2021 Mar 16;325(11):1099-1100
pubmed: 33555287
Hum Vaccin Immunother. 2020 Nov 1;16(11):2789-2799
pubmed: 32271655
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17
pubmed: 33775692
Matern Child Health J. 2006 Sep;10(5 Suppl):S67-72
pubmed: 16721664
Am J Obstet Gynecol. 2020 Nov;223(5):764-768
pubmed: 32730899
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
Arch Intern Med. 2001 Dec 10-24;161(22):2702-8
pubmed: 11732935
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
Matern Child Health J. 2018 Jul;22(7):1016-1024
pubmed: 29417364
JAMA. 2020 Nov 17;324(19):1935-1936
pubmed: 33104157
Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
Eur J Epidemiol. 2021 Feb;36(2):197-211
pubmed: 33649879
Vaccine. 2018 Nov 26;36(49):7445-7455
pubmed: 30377064
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
Am J Obstet Gynecol MFM. 2020 May;2(2):100107
pubmed: 32292902
Lancet. 2021 Dec 19;396(10267):1979-1993
pubmed: 33220855
Am J Prev Med. 2009 Sep;37(3):231-4
pubmed: 19596538
Sci Transl Med. 2010 Dec 8;2(61):61mr1
pubmed: 21148125
Health Aff (Millwood). 2020 Aug;39(8):1419-1425
pubmed: 32543923
J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):43-51
pubmed: 22257615